Document is current
Any future updates will be listed below
-
Authors
Stadler, Daniela https://orcid.org/0000-0002-7342-9751
Kächele, Martin
Jones, Alisha N
Hess, Julia
Urban, Christian https://orcid.org/0000-0002-4080-2468
Schneider, Jessica
Xia, Yuchen
Oswald, Andreas
Nebioglu, Firat
Bester, Romina
Lasitschka, Felix
Ringelhan, Marc https://orcid.org/0000-0003-3131-5657
Ko, Chunkyu
Chou, Wen-Min
Geerlof, Arie
van de Klundert, Maarten A
Wettengel, Jochen M
Schirmacher, Peter
Heikenwälder, Mathias
Schreiner, Sabrina
Bartenschlager, Ralf https://orcid.org/0000-0001-5601-9307
Pichlmair, Andreas https://orcid.org/0000-0002-0166-1367
Sattler, Michael
Unger, Kristian
Protzer, Ulrike https://orcid.org/0000-0002-9421-1911
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (272983813-TRR179)
Deutsche Forschungsgemeinschaft (TRR237)
ALIOS BioPharma
- License Information
-
More Information
Article History
Received: 30 October 2019
Revised: 18 March 2021
Accepted: 23 March 2021
First Online: 9 May 2021
Conflict of interest
: The position of Daniela Stadler was in part financed by a research grant from ALIOS BioPharma. Ulrike Protzer is shareholder and board member of SCG Cell Therapy. The remaining authors declare no conflict of interest.
